IgA nephropathy, also known as Berger's disease, is a kidney disease that occurs when an antibody called immunoglobulin A (IgA) builds up in your kidneys.
The Imperial IgA Nephropathy Service provides expert care to patients with IgA nephropathy and is committed to improving the management and outcomes of IgAN nephropathy patients.
IgA nephropathy patients are reviewed and managed by a team of world-renowned experts in the pathology, pathogeness and treatment of IgA nephropathy. Our consultant team includes members of the International IgA Nephropathy Network Research Group and contribute to international guidance on IgA nephropathy management.
IgA nephropathy is a common cause of kidney disease and failure, especially in young people. IgA nephropathy is diagnosed on kidney biopsy and may cause protein and blood in the urine, and abnormal blood tests of kidney function. Unfortunately, the cause of IgA nephropathy is not known. This limits the development of effective treatments to prevent kidney damage in patients with IgA nephropathy.
Through clinical research, we are committed to improving our understanding and treatment of IgA nephropathy. We run a number of clinical research projects and trials in IgA nephropathy, providing opportunities for patients to access research resources and newly available treatments. Our IgA neprhopathy research is coordinated by the Centre for Inflammatory Disease, Imperial College London.
Hours: 9am – 1pm
Renal Outpatients Department,
Du Cane Road.
London. W12 OHS
Contact information: email@example.com
Clinic contact number: 0208 383 4268
Meet the team
- Professor Fred Tam
- Dr Nick Medjeral-Thomas
- Dr Tom Cairns
- Professor Terence Cook
About this page
- Last updated
- Author Giuseppe Prima